Jeffrey Settleman
Enzo Life Sciences (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Protein Kinase Regulation and GTPase Signaling, Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research, Melanoma and MAPK Pathways
Most-Cited Works
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → Epidermal growth factor receptor mutations in lung cancer(2007)3,115 cited
- → Systematic identification of genomic markers of drug sensitivity in cancer cells(2012)2,534 cited
- → Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK(2009)1,873 cited
- → Detection of Mutations in EGFR in Circulating Lung-Cancer Cells(2008)1,612 cited
- → Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways(2004)1,610 cited
- → EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib